With the progress of farming and foresting, the demand of agricultural pesticide has been remarkably increased and accordingly, its intoxication has been widely publicized. Among the pesticides, organophosphorus chemicals has been believed to be almost nontoxic because they are not accumulative in the tissue. This study is attempted to examine the effects of DDVP which has been used most frequently on the kidney. And they were divided into normal and experimental groups. The results obtained from this experiment are as follows. 1) BUN, serum creatinine are increased in the group of DDVP administered while serum cholinesterase is suppresed significantly. 2) Microscopically, swelling and degeneration of tubular cells and hyaline casts in tubules. Ultrastructually swelling of mitochondria, partial fragmentation of cristae and electron dense bodies in the kidney are observed in the group of DDVP administered.

No abstract available.

BACKGROUND/AIMS: Itopride is a newly developed prokinetic agent enhancing gastric motility through both antidopaminergic and anti-acetylcholinesterase actions. The importance of esophageal motor dysfunction in the pathogenesis of gastro-esophageal reflux disease (GERD) makes it interesting to examine the effect of itopride on esophageal acid exposure. METHODS: The effect of itopride on esophageal 24-hour acid reflux variables was studied in 26 patients with GERD symptoms, pre-entry total acid exposure time (pH<4) of more than 5% and mild esophagitis (Savary-Miller grade I, II) by endoscopy. Ambulatory 24-hour pH monitoring and symptom assessment were performed after treatment with itopride 50 mg or 100 mg t.i.d for 4 weeks by a randomization allocation schedule with an open label. RESULTS: In both itopride groups, total symptom scores were decreased after treatment significantly. Itopride 300 mg was significantly more effective than 150 mg in decreasing the total time and total percent time of intraesophageal pH below 4, and DeMeester score. Consequently, no serious adverse effects were reported after administration in both groups. CONCLUSIONS: Itopride 100 mg t.i.d is effective to decrease pathologic reflux in patients with GERD. Therefore, it has a therapeutic potential for this diseases.
Appointments and Schedules ; Endoscopy ; Esophagitis ; Gastroesophageal Reflux* ; Humans ; Hydrogen-Ion Concentration ; Random Allocation ; Symptom Assessment